Ocugen, Inc.OCGNNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P38
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -4.30% |
| Q3 2025 | 32.68% |
| Q2 2025 | -11.82% |
| Q1 2025 | 14.95% |
| Q4 2024 | 2.24% |
| Q3 2024 | -8.92% |
| Q2 2024 | 30.41% |
| Q1 2024 | -28.18% |
| Q4 2023 | 34.85% |
| Q3 2023 | -51.64% |
| Q2 2023 | 43.28% |
| Q1 2023 | -40.91% |
| Q4 2022 | 10.18% |
| Q3 2022 | 73.44% |
| Q2 2022 | 13.80% |
| Q1 2022 | 11.45% |
| Q4 2021 | 13.07% |
| Q3 2021 | -66.68% |
| Q2 2021 | 556.44% |
| Q1 2021 | 80.21% |
| Q4 2020 | 7.83% |
| Q3 2020 | -9.33% |
| Q2 2020 | -1.33% |
| Q1 2020 | -5.44% |
| Q4 2019 | 33.82% |
| Q3 2019 | 192.70% |
| Q2 2019 | -71.83% |
| Q1 2019 | -52.42% |
| Q4 2018 | -27.09% |
| Q3 2018 | 2.36% |
| Q2 2018 | 35.67% |
| Q1 2018 | -2.38% |
| Q4 2017 | -3.50% |
| Q3 2017 | -17.11% |
| Q2 2017 | -6.57% |
| Q1 2017 | -15.29% |
| Q4 2016 | 8.95% |
| Q3 2016 | -15.77% |
| Q2 2016 | 3.72% |
| Q1 2016 | -3.24% |